Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.57 CAD | -2.62% | -3.80% | +7.32% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.32% | 422M | |
+4.27% | 70.78B | |
+10.72% | 9.15B | |
-15.34% | 4.84B | |
+34.54% | 4.22B | |
+5.09% | 3.92B | |
+17.30% | 2.55B | |
-24.15% | 2.26B | |
-28.33% | 2.24B | |
+6.23% | 1.92B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics : Earnings Flash (GUD.TO) KNIGHT THERAPEUTICS Reports Q1 Revenue $46.069 Million